<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04365426</url>
  </required_header>
  <id_info>
    <org_study_id>1</org_study_id>
    <nct_id>NCT04365426</nct_id>
  </id_info>
  <brief_title>Effects of Oral Contraceptives on DNIC in Non-painful Healthy Women</brief_title>
  <official_title>Effects of Oral Contraceptives on Diffuse Noxious Inhibitory Stimulus (DNIC) in Non-painful Healthy Women</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universidad Vina del Mar</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Universidad Vina del Mar</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is tu assess the influence of oral contraceptives (OC) on diffuse
      noxious inhibitory control (DNIC) in healthy women, tested during high, low endogenous
      estrogens sessions and ovulatory period.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      After being informed about the study and it protocol, all patients giving written informed
      consent, will undergo to a cephalic (masseter) and extracephalic (finger) mechanical stimulus
      to evaluate the threshold of mechanical pain, and physiological records of systolic/diastolic
      pressure and heart rates. After, we will evaluate the threshold response and physiological
      rates to the same mechanical stimulus under a thermal (cold) conditional pain (TCP) at 3
      different moments of menstrual period in No contraceptive group (No OC) versus Contraceptive
      group (CO). Finally, we will compare the mechanical threshold response, physiological rates
      and pain perception between both groups.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 24, 2020</start_date>
  <completion_date type="Anticipated">January 2023</completion_date>
  <primary_completion_date type="Anticipated">January 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Diffuse Noxious Inhibitory Control Efficiency in oral contraceptive healthy women</measure>
    <time_frame>Baseline phase 1 (2-5 days), phase 2 (14-17 days), and phase 3 (21-27 days) after the beginning of menstrual period</time_frame>
    <description>The efficiency of diffuse noxious inhibitory control (DNIC) is a measure of one's ability to inhibit pain perception. DNIC efficiency is assessed by a psychophysical test that involves a mechanical pressure in the masseter (cephalic) and finger (extracephalic) stimulus as the &quot;test stimulus&quot; and a cold-water bath as the &quot;conditioning stimulus&quot;. The results of this test will be used as the primary outcome measure.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Contraceptive Usage</condition>
  <condition>Diffuse Noxious Inhibitory Control</condition>
  <arm_group>
    <arm_group_label>Oral contraceptive (OC)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Oral contraceptive patients will be tested to mechanical (cephalic and extracephalic) stimulus and cold pain stimulus.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>No oral contraceptive (No OC)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>No oral contraceptive patients will be tested to mechanical (cephalic and extracephalic) stimulus and cold pain stimulus.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Mechanical stimulus</intervention_name>
    <description>Electrical dynamometer to measure mechanical pressure</description>
    <arm_group_label>No oral contraceptive (No OC)</arm_group_label>
    <arm_group_label>Oral contraceptive (OC)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Thermal (cold) stimulus</intervention_name>
    <description>Water cold bath</description>
    <arm_group_label>No oral contraceptive (No OC)</arm_group_label>
    <arm_group_label>Oral contraceptive (OC)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Oral contraceptive (OC)</intervention_name>
    <description>Oral contraceptive (OC)</description>
    <arm_group_label>Oral contraceptive (OC)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>No oral contraceptive (No OC)</intervention_name>
    <description>No oral contraceptive (No OC)</description>
    <arm_group_label>No oral contraceptive (No OC)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy women with oral contraceptive treatment (for at least 3 consecutive months),
             greater than or equal to 15 years old.

          -  Healthy women without oral contraceptive treatment, greater than or equal to 15 years
             old.

          -  Non pregnant women.

          -  Not under convulsive, chronic pain, antidepresive, antihypertensive, pharmacological
             treatments

          -  Without systemic pathologies.

        Exclusion Criteria:

          -  Treatment of a pain, depression, hypertension, convulsion condition with or without
             medication.

          -  Regular use of benzodiazepines.

          -  Systemic pathologies

          -  Pregnant women

          -  Menopausal women
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>15 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Nicolás Pinto-Pardo, DDS, Ms, Ph.D</last_name>
    <role>Principal Investigator</role>
    <affiliation>Universidad Vina del Mar</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Nicolás Pinto-Pardo, DDS, Ms, PH.D</last_name>
    <phone>+56996189688</phone>
    <email>nicolas.pinto@uvm.cl</email>
  </overall_contact>
  <location>
    <facility>
      <name>Universidad Viña del Mar</name>
      <address>
        <city>Viña Del Mar</city>
        <state>Valparaiso</state>
        <country>Chile</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nicolás Pinto-Pardo, DDS, Ms, Ph.D</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Chile</country>
  </location_countries>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>April 24, 2020</study_first_submitted>
  <study_first_submitted_qc>April 27, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">April 28, 2020</study_first_posted>
  <last_update_submitted>April 27, 2020</last_update_submitted>
  <last_update_submitted_qc>April 27, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 28, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Universidad Vina del Mar</investigator_affiliation>
    <investigator_full_name>Nicolás Pinto Pardo</investigator_full_name>
    <investigator_title>DDS, Msc, Ph.D</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Contraceptive Agents</mesh_term>
    <mesh_term>Contraceptives, Oral</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

